Apogee Therapeutics, Inc. APGE Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s retained earnings?
- Apogee Therapeutics, Inc. (APGE) reported retained earnings of -$635.87M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s retained earnings changed year-over-year?
- Apogee Therapeutics, Inc.'s retained earnings decreased by 76.0% year-over-year, from -$361.26M to -$635.87M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s retained earnings?
- Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s retained earnings has grown at a 141.7% compound annual growth rate (CAGR), from -$39.79M to -$561.76M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.